Horizon Pharma proposes to buy Depomed for $1.75 billion By: MarketWatch July 07, 2015 at 08:11 AM EDT Ireland-based Horizon Pharma proposed to buy Depomed for $1.75 billion, but Depomed has rejected the deal. Read More >> Related Stocks: Depomed Inc Horizon Therapeutics Macy's